Received Nov 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | G77F3 | — |
maladministration of the diluent only portion of a Shingrix vaccine; maladministration of the diluent only portion of a Shingrix vaccine; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 49-year-old female patient who received Herpes zoster (Shingrix) (batch number G77F3, expiry date 05-JUN-2027) for prophylaxis. On 14-NOV-2025, the patient received the 1st dose of Shingrix. On 14-NOV-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: maladministration of the diluent only portion of a Shingrix vaccine) and inappropriate dose of vaccine administered (Verbatim: maladministration of the diluent only portion of a Shingrix vaccine). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 17-NOV-2025 The registered nurse had requested data for actions after the maladministration of the diluent-only portion of a Shingrix vaccine. Shingrix was administered on Friday, 14-Nov-2025. This was the patient's first dose of Shingrix.